Note 4 - Inventories	12 Months Ended
Dec. 31, 2023
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 4 – INVENTORIES Inventories at December 31, 2023 totaled $927,111, and inventories at December 31, 2022 totaled $744,793. Our inventory consists of work in process material for our Theranostics Products, Cobalt Products, and Nuclear Medicine Products segments.

The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 330
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//330/tableOfContent

Name:	us-gaap_InventoryDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration